SUNSHINE PHARMA Announces Change of Company Secretary, Authorized Representative and Process Agent

Stock News10-30

SUNSHINE PHARMA (06887) has issued an announcement that Mr. Zheng Chengjie has resigned as the company secretary of the company, the authorized representative of the company as required under Rule 3.05 of the Listing Rules of The Stock Exchange of Hong Kong Limited, and the agent of the company in Hong Kong for accepting service of legal process documents and notices as required under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) (the process agent), with effect from 30 October 2026.

Ms. Ou Yongxian has been appointed as the company secretary, authorized representative and process agent, with effect from 30 October 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment